Laurent Chouchana

“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers

Alexandre O. Gérard, Serena Romani, Audrey Fresse et al. · Therapies · 2020 · 147 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns

Anthony Touafchia, Haleh Bagheri, Didier Carrié et al. · Clinical Microbiology and Infection · 2021 · 112 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10

Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

Naïm Ouldali, Haleh Bagheri, Francesco Salvo et al. · The Lancet Regional Health - Europe · 2022 · 69 citations · Full text

Medicine, Infectious Diseases, Pediatrics +16

Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)

Matthieu Grégoire, Caroline Monchaud, Stéphane Bouchet et al. · Therapies · 2022 · 68 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Phenome-Wide Association Studies on a Quantitative Trait: Application to TPMT Enzyme Activity and Thiopurine Therapy in Pharmacogenomics

Antoine Neuraz, Laurent Chouchana, Georgia Malamut et al. · PLoS Computational Biology · 2013 · 55 citations · Full text

Medicine, Pharmacology, Medical Genetics +14